BaseSpace
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Heart, Biofuel, Fenofibrate, rs2300478, FOXP1, T cell differentiation, HIV infection)
Bookmark Forward

QuickView for gp120 (gene)


Body Atlas

Most Correlated Tissues

  1. T Lymphocyte (CD8+) of peripheral blood
  2. Spleen
  3. Plasma cell of spleen
  4. T Lymphocyte (CD4+) of peripheral blood
  5. B lymphocyte (IgM memory) of spleen
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Hutchinson-Gilford syndrome
  2. Ebola virus disease
  3. Alpha-1-antitrypsin deficiency
  4. Disease due to Orthopoxvirus
  5. High fat diet
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. styrene oxide
  2. Carisoprodol
  3. Alcuronium
  4. IL24 protein, human
  5. clorsulon
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. THAP7-AS1
  2. SF3A3
  3. BAZ1B
  4. NEDD9
  5. HR
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Temsavir blocks the immunomodulatory activities of HIV-1 soluble gp120.
  2. The sensitivity of HIV-1 gp120 polymorphs to inhibition by temsavir correlates to temsavir binding o…
  3. gp120-derived amyloidogenic peptides form amyloid fibrils that increase HIV-1 infectivity.
  4. IgG1-b12-HIV-gp120 Interface in Solution: A Computational Study.
  5. Scyllatoxin-based peptide design for E. coli expression and HIV gp120 binding.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Safety and Immunogenicity of Clade C ALVAC and gp120 HIV Vaccine
  2. Long-term Immunogenicity of the HIV gp120-NefTat/AS01B Vaccine (GSK SB732461)
  3. Evaluating the Safety and Immunogenicity of Polyvalent DNA/gp120 HIV Vaccine in Healthy, HIV-uninfec…
  4. A Clinical Trial in Healthy, HIV-1-Uninfected Adult Participants to Compare the Safety, Tolerability…
  5. Evaluating the Safety and Immunogenicity of a Prime-boost Vaccine Regimen of GEO-D02 DNA and MVA/HIV…
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.